Intrabone hematopoietic stem cell gene therapy for adult and pediatric patients affected by transfusion-dependent ß-thalassemia

…, M Coppola, G Viarengo, L Santoleri, G Graziadei… - Nature medicine, 2019 - nature.com
ß-thalassemia is caused by ß-globin gene mutations resulting in reduced (β + ) or absent (β
0 ) hemoglobin production. Patient life expectancy has recently increased, but the need for …

[HTML][HTML] Elevated liver iron concentration is a marker of increased morbidity in patients with β thalassemia intermedia

…, MD Cappellini, JC Wood, I Motta, G Graziadei… - …, 2011 - ncbi.nlm.nih.gov
Background Patients with β thalassemia intermedia can have substantial iron overload,
irrespectively of their transfusion status, secondary to increased intestinal iron absorption. This …

[HTML][HTML] Recommendations regarding splenectomy in hereditary hemolytic anemias

…, L De Franceschi, C Pignata, G Graziadei… - …, 2017 - ncbi.nlm.nih.gov
Hereditary hemolytic anemias are a group of disorders with a variety of causes, including
red cell membrane defects, red blood cell enzyme disorders, congenital dyserythropoietic …

[HTML][HTML] SARS‐CoV‐2 infection in beta thalassemia: preliminary data from the Italian experience

…, F Bonetti, B Gianesin, G Graziadei… - American journal of …, 2020 - ncbi.nlm.nih.gov
… Pinto, 3 Manuela Balocco, 3 Filomena Longo, 4 Federico Bonetti, 5 Barbara Gianesin, 6
Giovanna Graziadei, 2 Maria D. Cappellini, 1 Lucia De Franceschi, 7 , [Link] Antonio Piga, 4 , […

Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo …

…, V Voi, E Cassinerio, A De, G Graziadei… - The Lancet …, 2022 - thelancet.com
Background In patients with non-transfusion-dependent β-thalassaemia, haemoglobin
concentrations lower than 10 g/dL are associated with a higher risk of morbidity, mortality, and …

[HTML][HTML] Sotatercept, a novel transforming growth factor β ligand trap, improves anemia in β-thalassemia: a phase II, open-label, dose-finding study

…, JB Arlet, JA Ribeil, M Garbowski, G Graziadei… - …, 2019 - ncbi.nlm.nih.gov
β-thalassemia, a hereditary blood disorder caused by defective synthesis of hemoglobin β
globin chains, leads to ineffective erythropoiesis and chronic anemia that may require blood …

Overall and complication‐free survival in a large cohort of patients with β‐thalassemia major followed over 50 years

…, MR Gamberini, VM Pinto, G Graziadei… - American Journal of …, 2023 - Wiley Online Library
We report data on survival and complications for a longitudinal cohort of 709 transfusion‐dependent
β‐thalassemia major patients (51.1% males) born between 1970 and 1997 and …

Membrane‐bound iron contributes to oxidative damage of β‐thalassaemia intermedia erythrocytes

D Tavazzi, L Duca, G Graziadei… - British journal of …, 2001 - Wiley Online Library
Iron‐dependent oxidative reactions in β‐thalassaemic erythrocyte membranes are involved
in premature cell removal and anaemia. We studied 22 β‐thalassaemia intermedia patients (i…

[HTML][HTML] Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study

…, S Daar, M Karimi, A El-Beshlawy, G Graziadei… - …, 2014 - ncbi.nlm.nih.gov
… Musallam, 1, 2 Maria Domenica Cappellini, 1 Shahina Daar, 3 Mehran Karimi, 4 Amal El-Beshlawy,
5 Giovanna Graziadei, 1 Matthew Magestro, 6 Jerome Wulff, 7 Guilhem Pietri, 7 and Ali T …

[HTML][HTML] Severe asthma exacerbation: role of acute Chlamydophila pneumoniae and Mycoplasma pneumoniae infection

R Cosentini, P Tarsia, C Canetta, G Graziadei… - Respiratory …, 2008 - Springer
Background Chlamydophila pneumoniae and Mycoplasma pneumoniae are associated with
acute exacerbation of bronchial asthma (AEBA). The aim of this study was to evaluate the …